HummingFlow: novel single twist-drill access for ventricular drainage, irrigation, monitoring, and automated local drug delivery in subarachnoid hemorrhage

J Neurosurg. 2023 Mar 31;139(4):1036-1041. doi: 10.3171/2023.2.JNS23295. Print 2023 Oct 1.

Abstract

Objective: The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage (aSAH) remains one of the most important targets for neurocritical care. Advances in monitoring technology have facilitated a more thorough understanding of the pathophysiology and therapeutic approaches, but interventions are generally limited to either systemic therapies or passive CSF drainage. The authors present a novel approach that combines a multimodal monitoring bolt-based system with an irrigating ventricular drain capable of delivering intrathecal medications and describe their early experience in patients with aSAH.

Methods: The authors performed a retrospective review of cases treated with the combined Hummingbird multimodal bolt system and the IRRAflow irrigating ventriculostomy.

Results: Nine patients were treated with the combined multimodal bolt system with irrigating ventriculostomy approach. The median number of days to clearance of the third and fourth ventricles was 3 days in patients with obstructive intraventricular hemorrhage. Two patients received intrathecal alteplase for intraventricular hemorrhage clearance, and 2 patients received intrathecal nicardipine as rescue therapy for severe symptomatic angiographic vasospasm.

Conclusions: Combined CSF drainage, irrigation, multimodality monitoring, and automated local drug delivery are feasible using a single twist-drill hole device. Further investigation of irrigation settings and treatment approaches in high-risk cases is warranted.

Keywords: intracranial; irrigating ventriculostomy; multimodal monitoring; novel; subarachnoid hemorrhage; vascular disorders.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Cerebral Hemorrhage / drug therapy
  • Drainage
  • Humans
  • Nicardipine
  • Subarachnoid Hemorrhage* / drug therapy
  • Subarachnoid Hemorrhage* / therapy
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome
  • Vasospasm, Intracranial* / drug therapy
  • Vasospasm, Intracranial* / etiology

Substances

  • Nicardipine
  • Tissue Plasminogen Activator